Cc1[nH]c(C)c(S(=O)(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)c1C(=O)N1CCCCC1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?